| | | |
Fatty acid abundance (mol %)
|
|---|
|
Fatty acids in liver lipids
|
RD
|
SFA
|
ALA
|
DHA
|
EPA
|
|---|
|
Saturated fatty acids
| | | | |
|
14:00
|
Myrisitic acid
|
1.0 ± 0.1
|
0.8 ± 0.07
|
0.8 ± 0.08
|
0.6 ± 0.07
|
0.7 ± 0.06
|
|
16:00
|
Palmitic acid
|
21.4 ± 1.9
|
19.6 ± 1.8
|
20.6 ± 1.8
|
19.4 ± 1.6
|
19.9 ± 2.0
|
|
18:00
|
Stearic acid
|
17.7 ± 1.1
|
22.4 ± 2.0
|
19.4 ± 2.1
|
18.6 ± 1.8
|
21.6 ± 1.8
|
|
Total SFAs
|
40.2 ± 2.9
|
42.8 ± 3.9
|
40.9 ± 2.5
|
38.7 ± 3.4
|
42.3 ± 3.9
|
|
Monounsaturated fatty acids (MUFA)
| | | | |
|
16:1ω-7
|
Palmitoleic acid
|
0.4 ± 0.05
|
0.7 ± 0.08
|
0.5 ± 0.06
|
0.5 ± 0.06
|
0.7 ± 0.08
|
|
18:1 ω -9
|
Oleic acid
|
9.2 ± 0.9
|
10.1 ± 1.1
|
7.1 ± 0.8
|
6.3 ± 0.5
|
7.6 ± 0.8
|
|
Total MUFA
|
9.6 ± 0.9
|
10.9 ± 0.9
|
7.7 ± 0.7
|
6.8 ± 0.5
|
8.3 ± 0.7
|
|
Polyunsaturated fatty acids (PUFA)
| | | | |
|
18:2 ω6
|
Linoleic
|
27.4 ± 1.9a
|
15.4 ± 1.4b
|
17.0 ± 1.5b
|
13.6 ± 1.4b
|
14.8 ± 1.5b
|
|
18:3 ω6
|
γ- Linolenic acid
|
0.4 ± 0.05a
|
0.1 ± 0.01b
|
0.1 ± 0.01b
|
0.0 ± 0.0
|
0.0 ± 0.0
|
|
20:4 ω6
|
Arachidonic acid
|
11.3 ± 1.3a
|
16.5 ± 1.5b
|
12.2 ± 1.1a
|
9.5 ± 0.8c
|
8.2 ± 0.8c
|
|
Total n-6 PUFA
|
39.2 ± 3.9a
|
32.2 ± 3.2a
|
29.4 ± 2.9a,b
|
23.3 ± 2.3b
|
23.0 ± 2.2b
|
|
18:3 ω3
|
α-Linolenic acid
|
1.1 ± 0.1a
|
0.1 ± 0.01b
|
1.7 ± 0.2a
|
0.1 ± 0.01b
|
0.2 ± 0.02b
|
|
20:5 ω3
|
Eicosapentenoic acid
|
0.4 ± 0.03
|
0.4 ± 0.04
|
3.1 ± 0.03
|
2.1 ± 0.2
|
7.1 ± 0.5
|
|
22:6 ω3
|
Docosahexenoic acid
|
9.3 ± 0.9
|
13.3 ± 1.2
|
16.9 ± 1.7
|
28.7 ± 2.5
|
18.7 ± 1.9
|
|
Total ω n-3 PUFA
|
10.9 ± 1.1a
|
13.9 ± 1.2a
|
21.9 ± 2.2b
|
31.0 ± 3.1c
|
26.1 ± 2.5c
|
|
Total PUFA
|
50.1 ± 4.9
|
46.2 ± 4.6
|
51.3 ± 4.8
|
54.3 ± 4.9
|
49.2 ± ±4.7
|
- Fatty acids are expressed as mole %. Fatty acids changed among the different maternal dietary treatments appear in bold. Means (n = 7) without a common letter (a, b or c) difference p < 0.05 between the maternal dietary treatments indicated in the x-axis, as described in Methods.
